Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer To Buy Trillium For $2.26bn In A Hematology Pipeline Play

Aug 23 2021

• By Jessica Merrill

shopping cart — Pfizer is shopping for new clinical-stage assets • Source: Alamy

Related Content

Gilead Calls Forty Seven Buyout Complementary To Kite, Other IO Efforts

Mar 02 2020

Pfizer Oncology Pipeline Shows Pivot To Targeted Therapies

Sep 22 2020

$2bn AbbVie Deal Puts I-Mab On Global Immuno-Oncology Map

Sep 04 2020

Gilead Teases Big Cancer Drug Readouts In Second Half

Jul 30 2021

Arvinas, Pfizer Partner To Pursue Best-In-Class Breast Cancer Strategy

Jul 22 2021

Related Companies

Pfizer Inc.

Gilead Sciences, Inc.

Forty Seven Inc.

Arvinas, Inc.

I-Mab

ALX Oncology, Inc.

Merck & Co., Inc.

Additional Topics

Deals M & A Business Strategies ImmunoOncology Cancer BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.